National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care West, Bristol, UK.
Centre for Academic Primary Care.
Br J Gen Pract. 2018 Oct;68(675):e682-e693. doi: 10.3399/bjgp18X698873. Epub 2018 Sep 10.
Clinicians commonly prescribe antibiotics to prevent major adverse outcomes in children presenting in primary care with cough and respiratory symptoms, despite limited meaningful evidence of impact on these outcomes.
To estimate the effect of children's antibiotic prescribing on adverse outcomes within 30 days of initial consultation.
Secondary analysis of 8320 children in a multicentre prospective cohort study, aged 3 months to <16 years, presenting in primary care across England with acute cough and other respiratory symptoms.
Baseline clinical characteristics and antibiotic prescribing data were collected, and generalised linear models were used to estimate the effect of antibiotic prescribing on adverse outcomes within 30 days (subsequent hospitalisations and reconsultation for deterioration), controlling for clustering and clinicians' propensity to prescribe antibiotics.
Sixty-five (0.8%) children were hospitalised and 350 (4%) reconsulted for deterioration. Clinicians prescribed immediate and delayed antibiotics to 2313 (28%) and 771 (9%), respectively. Compared with no antibiotics, there was no clear evidence that antibiotics reduced hospitalisations (immediate antibiotic risk ratio [RR] 0.83, 95% confidence interval [CI] = 0.47 to 1.45; delayed RR 0.70, 95% CI = 0.26 to 1.90, overall = 0.44). There was evidence that delayed (rather than immediate) antibiotics reduced reconsultations for deterioration (immediate RR 0.82, 95% CI = 0.65 to 1.07; delayed RR 0.55, 95% CI = 0.34 to 0.88, overall = 0.024).
Most children presenting with acute cough and respiratory symptoms in primary care are not at risk of hospitalisation, and antibiotics may not reduce the risk. If an antibiotic is considered, a delayed antibiotic prescription may be preferable as it is likely to reduce reconsultation for deterioration.
尽管临床医生对儿童初级保健中咳嗽和呼吸症状进行抗生素预防治疗的效果存在争议,但是他们还是普遍采用这种治疗方法来预防主要不良结局。
评估儿童抗生素治疗对初始就诊后 30 天内不良结局的影响。
这是一项对英格兰各地初级保健机构中 8320 名 3 个月至<16 岁的急性咳嗽和其他呼吸症状儿童进行的多中心前瞻性队列研究的二次分析。
收集基线临床特征和抗生素处方数据,并使用广义线性模型来估计抗生素治疗对 30 天内不良结局(后续住院和因恶化再次就诊)的影响,同时控制聚类和医生开具抗生素的倾向。
65 名(0.8%)儿童住院,350 名(4%)因恶化而再次就诊。临床医生分别为 2313 名(28%)和 771 名(9%)儿童开具了即刻和延迟抗生素。与不使用抗生素相比,抗生素治疗并未明显降低住院率(即刻抗生素风险比 [RR] 0.83,95%置信区间 [CI] = 0.47 至 1.45;延迟 RR 0.70,95% CI = 0.26 至 1.90,总体 RR = 0.44)。有证据表明,延迟(而非即刻)抗生素治疗可降低因恶化而再次就诊的发生率(即刻 RR 0.82,95% CI = 0.65 至 1.07;延迟 RR 0.55,95% CI = 0.34 至 0.88,总体 RR = 0.024)。
在初级保健中就诊的大多数急性咳嗽和呼吸症状儿童不存在住院风险,抗生素治疗可能无法降低风险。如果需要使用抗生素,延迟使用可能更优,因为这可能会降低因恶化而再次就诊的发生率。